Cory Ferguson

Cory Ferguson is an accomplished professional in regulatory affairs with extensive experience in the biopharmaceutical industry. Currently serving as Executive Director of Regulatory Affairs at SpringWorks Therapeutics since September 2023, Cory has held key leadership positions at several companies, including Executive Director and Senior Director of Regulatory Strategy at Mersana Therapeutics, and Senior Director of Regulatory Strategy at GSK. Prior experience includes roles at TESARO, Inc., Millennium Pharmaceuticals, Vertex Pharmaceuticals, and Massachusetts General Hospital, demonstrating a strong background in managing regulatory affairs and strategy across various organizations. Cory holds a BA in Comparative Politics and Spanish from Bowdoin College and an MHA in Healthcare Administration from Suffolk University - Sawyer Business School.